Phibro Animal Health (PAHC) Finished Goods (2013 - 2026)

Phibro Animal Health has reported Finished Goods for 14 years, with the latest figure at $313.0 million in Q2 2026.

• On a quarterly basis, Finished Goods rose 23.3% year-over-year to $313.0 million in Q2 2026; TTM through Jun 2026 was $313.0 million, a 23.3% increase from a year earlier, with the FY2026 full-year figure at $313.0 million, up 23.3% from the prior year.
• Finished Goods was $313.0 million for Q2 2026 at Phibro Animal Health, down from $318.0 million in the prior quarter.
• The five-year high for Finished Goods was $318.0 million in Q1 2026, with the low at $151.8 million in Q1 2022.
• Average Finished Goods over 5 years is $215.6 million, with a median of $182.6 million recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: Finished Goods dropped 3.0% in 2024, then jumped 63.76% in 2025.
• Over 5 years, Finished Goods stood at $172.4 million in 2022, then gained by 7.05% to $184.6 million in 2023, then soared by 38.16% to $255.0 million in 2024, then advanced by 21.43% to $309.7 million in 2025, then advanced by 1.07% to $313.0 million in 2026.
• The last three Finished Goods figures came in at $313.0 million (Q2 2026), $318.0 million (Q1 2026), and $309.7 million (Q4 2025), per Business Quant data.